Altered gut microbiota in individuals with episodic and chronic migraine

Dongeun Yong; Hakbae Lee; Hyung Gyu Min; Kyungnam Kim; Hyun Seok Oh; Min Kyung Chu

doi:10.1038/s41598-023-27586-4

Altered gut microbiota in individuals with episodic and chronic migraine

Dongeun Yong, Hakbae Lee, Hyung Gyu Min, Kyungnam Kim, Hyun Seok Oh, Min Kyung Chu

Department of Laboratory Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Emerging evidence reveals a close association between gut microbiota and human neurological disorders. The present study aimed to assess whether the composition of gut microbiota in participants with episodic migraine (EM) and chronic migraine (CM) was altered in comparison to that of the controls. This study was a cross-sectional, case–control study. The gut microbiota were evaluated by the partial, targeted sequencing of the 16S rRNA V3–V4 region. This study enrolled 42 and 45 participants with EM and CM, respectively, and 43 controls. Alpha and beta diversities revealed no significant difference among the three groups; however, the microbiota composition at the class, order, family, and genus levels differed significantly between EM and the control, CM and the control, and the EM and CM groups. Moreover, higher composition of PAC000195_g was significantly associated with a lower headache frequency among the five genera that exhibited significantly different microbiota composition in EM and CM. Agathobacter revealed a significant negative association with severe headache intensity. The findings of the present study provide evidence of altered gut microbiota in EM and CM. These findings will help in understanding the course and treatment of migraine.

Original language	English
Article number	626
Journal	Scientific reports
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41598-023-27586-4
Publication status	Published - 2023 Dec

Bibliographical note

Funding Information:
This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant No.: HV22C0106) and a National Research Foundation of Korea (NRF) grant from the Korean government (MSIT) (2022R1A2C1091767).

Funding Information:
Author MKC was a site investigator for a multicenter trial sponsored by Biohaven Pharmaceuticals, Allergan Korea, and the Ildong Pharmaceutical Company. He has received lecture honoraria from Eli Lilly and Company, Handok-Teva, and Ildong Pharmaceutical Company over the past 36 months. He received grants from Yonsei University College of Medicine (6–2021-0229), the Korea Health Industry Development Institute (KHIDI) (HV22CO106) and National Research Foundation of Korea (2022R1A2C1091767). Author HSO is employed by CJ Bioscience Inc. The other authors declare that they have no competing interests.

Publisher Copyright:
© 2023, The Author(s).

All Science Journal Classification (ASJC) codes

General

Access to Document

10.1038/s41598-023-27586-4

Cite this

@article{eb9c1590dc334685a8170763c9aca2b6,

title = "Altered gut microbiota in individuals with episodic and chronic migraine",

abstract = "Emerging evidence reveals a close association between gut microbiota and human neurological disorders. The present study aimed to assess whether the composition of gut microbiota in participants with episodic migraine (EM) and chronic migraine (CM) was altered in comparison to that of the controls. This study was a cross-sectional, case–control study. The gut microbiota were evaluated by the partial, targeted sequencing of the 16S rRNA V3–V4 region. This study enrolled 42 and 45 participants with EM and CM, respectively, and 43 controls. Alpha and beta diversities revealed no significant difference among the three groups; however, the microbiota composition at the class, order, family, and genus levels differed significantly between EM and the control, CM and the control, and the EM and CM groups. Moreover, higher composition of PAC000195_g was significantly associated with a lower headache frequency among the five genera that exhibited significantly different microbiota composition in EM and CM. Agathobacter revealed a significant negative association with severe headache intensity. The findings of the present study provide evidence of altered gut microbiota in EM and CM. These findings will help in understanding the course and treatment of migraine.",

author = "Dongeun Yong and Hakbae Lee and Min, {Hyung Gyu} and Kyungnam Kim and Oh, {Hyun Seok} and Chu, {Min Kyung}",

note = "Funding Information: This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant No.: HV22C0106) and a National Research Foundation of Korea (NRF) grant from the Korean government (MSIT) (2022R1A2C1091767). Funding Information: Author MKC was a site investigator for a multicenter trial sponsored by Biohaven Pharmaceuticals, Allergan Korea, and the Ildong Pharmaceutical Company. He has received lecture honoraria from Eli Lilly and Company, Handok-Teva, and Ildong Pharmaceutical Company over the past 36 months. He received grants from Yonsei University College of Medicine (6–2021-0229), the Korea Health Industry Development Institute (KHIDI) (HV22CO106) and National Research Foundation of Korea (2022R1A2C1091767). Author HSO is employed by CJ Bioscience Inc. The other authors declare that they have no competing interests. Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

doi = "10.1038/s41598-023-27586-4",

language = "English",

volume = "13",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Altered gut microbiota in individuals with episodic and chronic migraine

AU - Yong, Dongeun

AU - Lee, Hakbae

AU - Min, Hyung Gyu

AU - Kim, Kyungnam

AU - Oh, Hyun Seok

AU - Chu, Min Kyung

N1 - Funding Information: This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant No.: HV22C0106) and a National Research Foundation of Korea (NRF) grant from the Korean government (MSIT) (2022R1A2C1091767). Funding Information: Author MKC was a site investigator for a multicenter trial sponsored by Biohaven Pharmaceuticals, Allergan Korea, and the Ildong Pharmaceutical Company. He has received lecture honoraria from Eli Lilly and Company, Handok-Teva, and Ildong Pharmaceutical Company over the past 36 months. He received grants from Yonsei University College of Medicine (6–2021-0229), the Korea Health Industry Development Institute (KHIDI) (HV22CO106) and National Research Foundation of Korea (2022R1A2C1091767). Author HSO is employed by CJ Bioscience Inc. The other authors declare that they have no competing interests. Publisher Copyright: © 2023, The Author(s).

PY - 2023/12

Y1 - 2023/12

N2 - Emerging evidence reveals a close association between gut microbiota and human neurological disorders. The present study aimed to assess whether the composition of gut microbiota in participants with episodic migraine (EM) and chronic migraine (CM) was altered in comparison to that of the controls. This study was a cross-sectional, case–control study. The gut microbiota were evaluated by the partial, targeted sequencing of the 16S rRNA V3–V4 region. This study enrolled 42 and 45 participants with EM and CM, respectively, and 43 controls. Alpha and beta diversities revealed no significant difference among the three groups; however, the microbiota composition at the class, order, family, and genus levels differed significantly between EM and the control, CM and the control, and the EM and CM groups. Moreover, higher composition of PAC000195_g was significantly associated with a lower headache frequency among the five genera that exhibited significantly different microbiota composition in EM and CM. Agathobacter revealed a significant negative association with severe headache intensity. The findings of the present study provide evidence of altered gut microbiota in EM and CM. These findings will help in understanding the course and treatment of migraine.

AB - Emerging evidence reveals a close association between gut microbiota and human neurological disorders. The present study aimed to assess whether the composition of gut microbiota in participants with episodic migraine (EM) and chronic migraine (CM) was altered in comparison to that of the controls. This study was a cross-sectional, case–control study. The gut microbiota were evaluated by the partial, targeted sequencing of the 16S rRNA V3–V4 region. This study enrolled 42 and 45 participants with EM and CM, respectively, and 43 controls. Alpha and beta diversities revealed no significant difference among the three groups; however, the microbiota composition at the class, order, family, and genus levels differed significantly between EM and the control, CM and the control, and the EM and CM groups. Moreover, higher composition of PAC000195_g was significantly associated with a lower headache frequency among the five genera that exhibited significantly different microbiota composition in EM and CM. Agathobacter revealed a significant negative association with severe headache intensity. The findings of the present study provide evidence of altered gut microbiota in EM and CM. These findings will help in understanding the course and treatment of migraine.

UR - http://www.scopus.com/inward/record.url?scp=85146195152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85146195152&partnerID=8YFLogxK

U2 - 10.1038/s41598-023-27586-4

DO - 10.1038/s41598-023-27586-4

M3 - Article

C2 - 36635330

AN - SCOPUS:85146195152

SN - 2045-2322

VL - 13

JO - Scientific Reports

JF - Scientific Reports

IS - 1

M1 - 626

ER -

Altered gut microbiota in individuals with episodic and chronic migraine

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this